You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天壇生物(600161.SH):“人凝血酶原複合物”完成臨牀試驗
格隆匯 08-22 22:20

格隆匯8月22日丨天壇生物(600161.SH)公佈,近日,公司控股子公司成都蓉生藥業有限責任公司(“成都蓉生”)研製的“人凝血酶原複合物”完成了臨牀試驗並取得臨牀試驗總結報告。

臨牀試驗主要療效指標和次要療效指標均顯示,成都蓉生生產的人凝血酶原複合物治療乙型血友病的輸注效率值以及出血症狀和體徵的總改善率均達到預期水平,同時提高了乙型血友病患者體內的因子IX、II、VII、X活性水平,縮短了活化部分凝血活酶時間(APTT)。受試者全部進入安全分析集,研究顯示成都蓉生生產的人凝血酶原複合物的總體安全性良好

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account